Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 124

1.

Intensive multifactorial intervention for stable coronary artery disease: optimal medical therapy in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial.

Maron DJ, Boden WE, O'Rourke RA, Hartigan PM, Calfas KJ, Mancini GB, Spertus JA, Dada M, Kostuk WJ, Knudtson M, Harris CL, Sedlis SP, Zoble RG, Title LM, Gosselin G, Nawaz S, Gau GT, Blaustein AS, Bates ER, Shaw LJ, Berman DS, Chaitman BR, Weintraub WS, Teo KK; COURAGE Trial Research Group.

J Am Coll Cardiol. 2010 Mar 30;55(13):1348-58. doi: 10.1016/j.jacc.2009.10.062.

PMID:
20338496
[PubMed - indexed for MEDLINE]
Free Article
2.

Optimal medical therapy with or without percutaneous coronary intervention in older patients with stable coronary disease: a pre-specified subset analysis of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation) trial.

Teo KK, Sedlis SP, Boden WE, O'Rourke RA, Maron DJ, Hartigan PM, Dada M, Gupta V, Spertus JA, Kostuk WJ, Berman DS, Shaw LJ, Chaitman BR, Mancini GB, Weintraub WS; COURAGE Trial Investigators.

J Am Coll Cardiol. 2009 Sep 29;54(14):1303-8. doi: 10.1016/j.jacc.2009.07.013.

PMID:
19778673
[PubMed - indexed for MEDLINE]
Free Article
3.

The immediate impact of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial on the management of stable angina.

Atwater BD, Oujiri J, Wolff MR.

Clin Cardiol. 2009 Aug;32(8):E1-3. doi: 10.1002/clc.20524.

PMID:
19536842
[PubMed - indexed for MEDLINE]
4.

Risk factor control for coronary artery disease secondary prevention in large randomized trials.

Farkouh ME, Boden WE, Bittner V, Muratov V, Hartigan P, Ogdie M, Bertolet M, Mathewkutty S, Teo K, Maron DJ, Sethi SS, Domanski M, Frye RL, Fuster V.

J Am Coll Cardiol. 2013 Apr 16;61(15):1607-15. doi: 10.1016/j.jacc.2013.01.044.

PMID:
23500281
[PubMed - indexed for MEDLINE]
Free Article
5.

Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.

Shaw LJ, Berman DS, Maron DJ, Mancini GB, Hayes SW, Hartigan PM, Weintraub WS, O'Rourke RA, Dada M, Spertus JA, Chaitman BR, Friedman J, Slomka P, Heller GV, Germano G, Gosselin G, Berger P, Kostuk WJ, Schwartz RG, Knudtson M, Veledar E, Bates ER, McCallister B, Teo KK, Boden WE; COURAGE Investigators.

Circulation. 2008 Mar 11;117(10):1283-91. doi: 10.1161/CIRCULATIONAHA.107.743963. Epub 2008 Feb 11.

PMID:
18268144
[PubMed - indexed for MEDLINE]
Free Article
6.

Aggressive medical management of coronary artery disease versus mechanical revascularization.

Chiquette E, Chilton R.

Curr Atheroscler Rep. 2003 Mar;5(2):118-23. Review.

PMID:
12573197
[PubMed - indexed for MEDLINE]
7.

Gated myocardial perfusion single photon emission computed tomography in the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial, Veterans Administration Cooperative study no. 424.

Shaw LJ, Heller GV, Casperson P, Miranda-Peats R, Slomka P, Friedman J, Hayes SW, Schwartz R, Weintraub WS, Maron DJ, Dada M, King S, Teo K, Hartigan P, Boden WE, O'Rourke RA, Berman DS; COURAGE investigators.

J Nucl Cardiol. 2006 Sep;13(5):685-98.

PMID:
16945749
[PubMed - indexed for MEDLINE]
8.

Design and rationale of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial Veterans Affairs Cooperative Studies Program no. 424.

Boden WE, O'rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk W, Knudtson M, Dada M, Casperson P, Harris CL, Spertus JA, Shaw L, Chaitman BR, Mancini GB, Berman DS, Weintraub WS; COURAGE trial coprincipal investigators and study coordinators.

Am Heart J. 2006 Jun;151(6):1173-9.

PMID:
16781214
[PubMed - indexed for MEDLINE]
9.

Impact of an initial strategy of medical therapy without percutaneous coronary intervention in high-risk patients from the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial.

Maron DJ, Spertus JA, Mancini GB, Hartigan PM, Sedlis SP, Bates ER, Kostuk WJ, Dada M, Berman DS, Shaw LJ, Chaitman BR, Teo KK, O'Rourke RA, Weintraub WS, Boden WE; COURAGE Trial Research Group.

Am J Cardiol. 2009 Oct 15;104(8):1055-62. doi: 10.1016/j.amjcard.2009.05.056. Epub 2009 Aug 28.

PMID:
19801024
[PubMed - indexed for MEDLINE]
10.

Is Optimal Medical Therapy as Used in the COURAGE Trial Feasible for Widespread Use?

Maron DJ, Boden WE, Weintraub WS, Calfas KJ, O'Rourke RA.

Curr Treat Options Cardiovasc Med. 2011 Feb;13(1):16-25. doi: 10.1007/s11936-010-0104-7.

PMID:
21120640
[PubMed]
11.

API expert consensus document on management of ischemic heart disease.

Association of Physicians of India.

J Assoc Physicians India. 2006 Jun;54:469-80. Review.

PMID:
16909697
[PubMed - indexed for MEDLINE]
12.

The evolving pattern of symptomatic coronary artery disease in the United States and Canada: baseline characteristics of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial.

Boden WE, O'rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk W, Knudtson M, Dada M, Casperson P, Harris CL, Spertus JA, Shaw L, Chaitman BR, Mancini GB, Berman DS, Gau G, Weintraub WS; COURAGE Trial Co-Principal Investigators and Study Coordinators.

Am J Cardiol. 2007 Jan 15;99(2):208-12. Epub 2006 Nov 17.

PMID:
17223420
[PubMed - indexed for MEDLINE]
13.

Impact of optimal medical therapy with or without percutaneous coronary intervention on long-term cardiovascular end points in patients with stable coronary artery disease (from the COURAGE Trial).

Boden WE, O'Rourke RA, Teo KK, Maron DJ, Hartigan PM, Sedlis SP, Dada M, Labedi M, Spertus JA, Kostuk WJ, Berman DS, Shaw LJ, Chaitman BR, Mancini GB, Weintraub WS; COURAGE Trial Investigators.

Am J Cardiol. 2009 Jul 1;104(1):1-4. doi: 10.1016/j.amjcard.2009.02.059. Epub 2009 Apr 16.

PMID:
19576311
[PubMed - indexed for MEDLINE]
14.

Medical therapy versus coronary angioplasty in stable coronary artery disease: a critical review of the literature.

Blumenthal RS, Cohn G, Schulman SP.

J Am Coll Cardiol. 2000 Sep;36(3):668-73. Review. Erratum in: J Am Coll Cardiol 2001 Jan;37(1):339.

PMID:
10987582
[PubMed - indexed for MEDLINE]
Free Article
15.

Achievement of optimal medical therapy goals for U.S. adults with coronary artery disease: results from the REGARDS Study (REasons for Geographic And Racial Differences in Stroke).

Brown TM, Voeks JH, Bittner V, Brenner DA, Cushman M, Goff DC Jr, Glasser S, Muntner P, Tabereaux PB, Safford MM.

J Am Coll Cardiol. 2014 Apr 29;63(16):1626-33. doi: 10.1016/j.jacc.2013.12.042. Epub 2014 Feb 26.

PMID:
24534599
[PubMed - indexed for MEDLINE]
16.

The COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial: can we deliver on its promise?

O'Gara PT.

J Am Coll Cardiol. 2010 Mar 30;55(13):1359-61. doi: 10.1016/j.jacc.2009.11.061. No abstract available.

PMID:
20338497
[PubMed - indexed for MEDLINE]
Free Article
17.

Cholesterol and atherosclerosis: a contemporary perspective.

Kashyap ML.

Ann Acad Med Singapore. 1997 Jul;26(4):517-23. Review.

PMID:
9395824
[PubMed - indexed for MEDLINE]
18.

Medical therapy versus percutaneous coronary interventions for patients with stable and unstable coronary artery disease.

Pitt B.

Curr Atheroscler Rep. 2008 Aug;10(4):288-94. Review.

PMID:
18606099
[PubMed - indexed for MEDLINE]
19.

Evolving concepts in selecting optimal strategies for the management of patients with stable coronary disease: pharmacologic or revascularization therapy.

Tandar A, Boden WE.

Curr Opin Cardiol. 2009 Nov;24(6):591-5. doi: 10.1097/HCO.0b013e32833155e2. Review.

PMID:
19752728
[PubMed - indexed for MEDLINE]
20.

Frequency, predictors, and consequences of crossing over to revascularization within 12 months of randomization to optimal medical therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial.

Spertus JA, Maron DJ, Cohen DJ, Kolm P, Hartigan P, Weintraub WS, Berman DS, Teo KK, Shaw LJ, Sedlis SP, Knudtson M, Aslan M, Dada M, Boden WE, Mancini GB; Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Investigators and Coordinators.

Circ Cardiovasc Qual Outcomes. 2013 Jul;6(4):409-18. doi: 10.1161/CIRCOUTCOMES.113.000139. Epub 2013 Jul 9.

PMID:
23838107
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk